nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—ADRA1B—vas deferens—testicular cancer	0.38	0.906	CbGeAlD
Propericiazine—Abnormal pigmentation—Epirubicin—testicular cancer	0.0259	0.0446	CcSEcCtD
Propericiazine—Abnormal pigmentation—Doxorubicin—testicular cancer	0.024	0.0413	CcSEcCtD
Propericiazine—Ileus paralytic—Vinblastine—testicular cancer	0.0177	0.0304	CcSEcCtD
Propericiazine—Arrhythmia supraventricular—Ifosfamide—testicular cancer	0.0142	0.0245	CcSEcCtD
Propericiazine—Pigmentation disorder—Etoposide—testicular cancer	0.0131	0.0225	CcSEcCtD
Propericiazine—ADRA2A—seminal vesicle—testicular cancer	0.0123	0.0292	CbGeAlD
Propericiazine—Electrocardiogram ST segment depression—Epirubicin—testicular cancer	0.0108	0.0185	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Doxorubicin—testicular cancer	0.00996	0.0171	CcSEcCtD
Propericiazine—Amenorrhoea—Chlorambucil—testicular cancer	0.0095	0.0164	CcSEcCtD
Propericiazine—Deep vein thrombosis—Ifosfamide—testicular cancer	0.00907	0.0156	CcSEcCtD
Propericiazine—Dyskinesia—Chlorambucil—testicular cancer	0.00888	0.0153	CcSEcCtD
Propericiazine—ADRA2A—gonad—testicular cancer	0.00886	0.0211	CbGeAlD
Propericiazine—Venous thromboembolism—Epirubicin—testicular cancer	0.00831	0.0143	CcSEcCtD
Propericiazine—Venous thromboembolism—Doxorubicin—testicular cancer	0.00769	0.0132	CcSEcCtD
Propericiazine—Aggression—Bleomycin—testicular cancer	0.00735	0.0127	CcSEcCtD
Propericiazine—Pigmentation disorder—Epirubicin—testicular cancer	0.00732	0.0126	CcSEcCtD
Propericiazine—ADRA2A—female gonad—testicular cancer	0.0072	0.0172	CbGeAlD
Propericiazine—Pigmentation disorder—Doxorubicin—testicular cancer	0.00677	0.0117	CcSEcCtD
Propericiazine—ADRA2A—testis—testicular cancer	0.00639	0.0152	CbGeAlD
Propericiazine—Amenorrhoea—Ifosfamide—testicular cancer	0.00628	0.0108	CcSEcCtD
Propericiazine—Dyskinesia—Ifosfamide—testicular cancer	0.00587	0.0101	CcSEcCtD
Propericiazine—Infection—Carboplatin—testicular cancer	0.00575	0.0099	CcSEcCtD
Propericiazine—Liver injury—Cisplatin—testicular cancer	0.00565	0.00974	CcSEcCtD
Propericiazine—Pulmonary embolism—Ifosfamide—testicular cancer	0.00552	0.0095	CcSEcCtD
Propericiazine—Ventricular tachycardia—Ifosfamide—testicular cancer	0.00552	0.0095	CcSEcCtD
Propericiazine—Sudden death—Methotrexate—testicular cancer	0.0051	0.00879	CcSEcCtD
Propericiazine—Embolism venous—Epirubicin—testicular cancer	0.00484	0.00834	CcSEcCtD
Propericiazine—Pneumonia—Chlorambucil—testicular cancer	0.00469	0.00808	CcSEcCtD
Propericiazine—ADRA2A—lymph node—testicular cancer	0.00463	0.011	CbGeAlD
Propericiazine—Body temperature increased—Carboplatin—testicular cancer	0.00457	0.00788	CcSEcCtD
Propericiazine—Jaundice—Chlorambucil—testicular cancer	0.00455	0.00783	CcSEcCtD
Propericiazine—Embolism venous—Doxorubicin—testicular cancer	0.00448	0.00771	CcSEcCtD
Propericiazine—Deep vein thrombosis—Methotrexate—testicular cancer	0.00429	0.00739	CcSEcCtD
Propericiazine—Agranulocytosis—Vinblastine—testicular cancer	0.00399	0.00687	CcSEcCtD
Propericiazine—Nasal congestion—Cisplatin—testicular cancer	0.00379	0.00653	CcSEcCtD
Propericiazine—Hypokalaemia—Ifosfamide—testicular cancer	0.00365	0.00628	CcSEcCtD
Propericiazine—Pneumonia—Bleomycin—testicular cancer	0.00363	0.00626	CcSEcCtD
Propericiazine—Tremor—Chlorambucil—testicular cancer	0.00342	0.00588	CcSEcCtD
Propericiazine—Pneumonia—Dactinomycin—testicular cancer	0.00339	0.00584	CcSEcCtD
Propericiazine—Agitation—Chlorambucil—testicular cancer	0.00335	0.00577	CcSEcCtD
Propericiazine—Angioedema—Chlorambucil—testicular cancer	0.00333	0.00574	CcSEcCtD
Propericiazine—Agranulocytosis—Dactinomycin—testicular cancer	0.00314	0.00541	CcSEcCtD
Propericiazine—Hypokalaemia—Cisplatin—testicular cancer	0.00314	0.00541	CcSEcCtD
Propericiazine—Hyperglycaemia—Ifosfamide—testicular cancer	0.00312	0.00538	CcSEcCtD
Propericiazine—Pneumonia—Ifosfamide—testicular cancer	0.0031	0.00535	CcSEcCtD
Propericiazine—Confusional state—Chlorambucil—testicular cancer	0.003	0.00517	CcSEcCtD
Propericiazine—Infection—Chlorambucil—testicular cancer	0.00296	0.00509	CcSEcCtD
Propericiazine—Sweating increased—Cisplatin—testicular cancer	0.00291	0.00501	CcSEcCtD
Propericiazine—Liver injury—Epirubicin—testicular cancer	0.0029	0.005	CcSEcCtD
Propericiazine—Agranulocytosis—Ifosfamide—testicular cancer	0.00288	0.00496	CcSEcCtD
Propericiazine—Jaundice cholestatic—Epirubicin—testicular cancer	0.00278	0.00479	CcSEcCtD
Propericiazine—Amenorrhoea—Epirubicin—testicular cancer	0.00278	0.00479	CcSEcCtD
Propericiazine—Liver injury—Doxorubicin—testicular cancer	0.00269	0.00463	CcSEcCtD
Propericiazine—Sweating increased—Etoposide—testicular cancer	0.00266	0.00459	CcSEcCtD
Propericiazine—Pulmonary embolism—Methotrexate—testicular cancer	0.00261	0.0045	CcSEcCtD
Propericiazine—Dyskinesia—Epirubicin—testicular cancer	0.0026	0.00448	CcSEcCtD
Propericiazine—Amenorrhoea—Doxorubicin—testicular cancer	0.00257	0.00443	CcSEcCtD
Propericiazine—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00257	0.00443	CcSEcCtD
Propericiazine—Cardiac disorder—Ifosfamide—testicular cancer	0.00257	0.00443	CcSEcCtD
Propericiazine—Atrioventricular block—Epirubicin—testicular cancer	0.00252	0.00434	CcSEcCtD
Propericiazine—Arrhythmia—Ifosfamide—testicular cancer	0.00248	0.00426	CcSEcCtD
Propericiazine—Pneumonia—Etoposide—testicular cancer	0.00245	0.00422	CcSEcCtD
Propericiazine—Pulmonary embolism—Epirubicin—testicular cancer	0.00244	0.00421	CcSEcCtD
Propericiazine—Ventricular tachycardia—Epirubicin—testicular cancer	0.00244	0.00421	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—testicular cancer	0.00241	0.00414	CcSEcCtD
Propericiazine—Jaundice—Etoposide—testicular cancer	0.00238	0.00409	CcSEcCtD
Propericiazine—Body temperature increased—Chlorambucil—testicular cancer	0.00235	0.00405	CcSEcCtD
Propericiazine—Gynaecomastia—Methotrexate—testicular cancer	0.00234	0.00402	CcSEcCtD
Propericiazine—Constipation—Vinblastine—testicular cancer	0.00233	0.00402	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—testicular cancer	0.00233	0.00401	CcSEcCtD
Propericiazine—Confusional state—Bleomycin—testicular cancer	0.00232	0.004	CcSEcCtD
Propericiazine—Oedema—Bleomycin—testicular cancer	0.0023	0.00397	CcSEcCtD
Propericiazine—Infection—Bleomycin—testicular cancer	0.00229	0.00394	CcSEcCtD
Propericiazine—Agranulocytosis—Etoposide—testicular cancer	0.00228	0.00392	CcSEcCtD
Propericiazine—Vision blurred—Ifosfamide—testicular cancer	0.00227	0.00392	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—testicular cancer	0.00226	0.00389	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—testicular cancer	0.00226	0.00389	CcSEcCtD
Propericiazine—Cardiac disorder—Cisplatin—testicular cancer	0.00222	0.00382	CcSEcCtD
Propericiazine—Agitation—Ifosfamide—testicular cancer	0.00222	0.00382	CcSEcCtD
Propericiazine—Angioedema—Ifosfamide—testicular cancer	0.0022	0.0038	CcSEcCtD
Propericiazine—Hypersensitivity—Chlorambucil—testicular cancer	0.00219	0.00378	CcSEcCtD
Propericiazine—Photosensitivity—Methotrexate—testicular cancer	0.00216	0.00372	CcSEcCtD
Propericiazine—Hypotension—Bleomycin—testicular cancer	0.00215	0.00371	CcSEcCtD
Propericiazine—Oedema—Dactinomycin—testicular cancer	0.00215	0.0037	CcSEcCtD
Propericiazine—Infection—Dactinomycin—testicular cancer	0.00213	0.00368	CcSEcCtD
Propericiazine—Arrhythmia—Cisplatin—testicular cancer	0.00213	0.00368	CcSEcCtD
Propericiazine—Dyspnoea—Bleomycin—testicular cancer	0.00205	0.00354	CcSEcCtD
Propericiazine—Diarrhoea—Chlorambucil—testicular cancer	0.00204	0.00351	CcSEcCtD
Propericiazine—Cardiac disorder—Etoposide—testicular cancer	0.00203	0.0035	CcSEcCtD
Propericiazine—Photosensitivity—Epirubicin—testicular cancer	0.00202	0.00348	CcSEcCtD
Propericiazine—Hypersensitivity—Vinblastine—testicular cancer	0.00201	0.00346	CcSEcCtD
Propericiazine—Confusional state—Ifosfamide—testicular cancer	0.00199	0.00342	CcSEcCtD
Propericiazine—Oedema—Ifosfamide—testicular cancer	0.00197	0.00339	CcSEcCtD
Propericiazine—Vision blurred—Cisplatin—testicular cancer	0.00196	0.00338	CcSEcCtD
Propericiazine—Infection—Ifosfamide—testicular cancer	0.00196	0.00337	CcSEcCtD
Propericiazine—Tremor—Cisplatin—testicular cancer	0.00195	0.00336	CcSEcCtD
Propericiazine—Hyperhidrosis—Ifosfamide—testicular cancer	0.0019	0.00328	CcSEcCtD
Propericiazine—Vomiting—Chlorambucil—testicular cancer	0.00189	0.00326	CcSEcCtD
Propericiazine—Increased appetite—Epirubicin—testicular cancer	0.00189	0.00325	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—testicular cancer	0.00187	0.00322	CcSEcCtD
Propericiazine—Diarrhoea—Vinblastine—testicular cancer	0.00187	0.00321	CcSEcCtD
Propericiazine—Hypotension—Ifosfamide—testicular cancer	0.00184	0.00317	CcSEcCtD
Propericiazine—Body temperature increased—Bleomycin—testicular cancer	0.00182	0.00314	CcSEcCtD
Propericiazine—Nausea—Chlorambucil—testicular cancer	0.00177	0.00304	CcSEcCtD
Propericiazine—Dyspnoea—Ifosfamide—testicular cancer	0.00176	0.00302	CcSEcCtD
Propericiazine—Somnolence—Ifosfamide—testicular cancer	0.00175	0.00301	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—testicular cancer	0.00175	0.00301	CcSEcCtD
Propericiazine—Vomiting—Vinblastine—testicular cancer	0.00173	0.00299	CcSEcCtD
Propericiazine—Body temperature increased—Dactinomycin—testicular cancer	0.0017	0.00293	CcSEcCtD
Propericiazine—Oedema—Cisplatin—testicular cancer	0.0017	0.00292	CcSEcCtD
Propericiazine—Hypersensitivity—Bleomycin—testicular cancer	0.0017	0.00292	CcSEcCtD
Propericiazine—Infection—Cisplatin—testicular cancer	0.00169	0.0029	CcSEcCtD
Propericiazine—Constipation—Ifosfamide—testicular cancer	0.00168	0.0029	CcSEcCtD
Propericiazine—Tachycardia—Cisplatin—testicular cancer	0.00166	0.00285	CcSEcCtD
Propericiazine—Hyperhidrosis—Cisplatin—testicular cancer	0.00164	0.00283	CcSEcCtD
Propericiazine—Asthma—Methotrexate—testicular cancer	0.00164	0.00282	CcSEcCtD
Propericiazine—Eosinophilia—Methotrexate—testicular cancer	0.00162	0.00279	CcSEcCtD
Propericiazine—Nausea—Vinblastine—testicular cancer	0.00162	0.00279	CcSEcCtD
Propericiazine—Hypokalaemia—Epirubicin—testicular cancer	0.00161	0.00278	CcSEcCtD
Propericiazine—Hypotension—Cisplatin—testicular cancer	0.00159	0.00273	CcSEcCtD
Propericiazine—Hypersensitivity—Dactinomycin—testicular cancer	0.00158	0.00273	CcSEcCtD
Propericiazine—Confusional state—Etoposide—testicular cancer	0.00157	0.0027	CcSEcCtD
Propericiazine—Body temperature increased—Ifosfamide—testicular cancer	0.00156	0.00268	CcSEcCtD
Propericiazine—Infection—Etoposide—testicular cancer	0.00154	0.00266	CcSEcCtD
Propericiazine—Asthma—Epirubicin—testicular cancer	0.00153	0.00264	CcSEcCtD
Propericiazine—Tachycardia—Etoposide—testicular cancer	0.00152	0.00261	CcSEcCtD
Propericiazine—Eosinophilia—Epirubicin—testicular cancer	0.00152	0.00261	CcSEcCtD
Propericiazine—Dyspnoea—Cisplatin—testicular cancer	0.00151	0.00261	CcSEcCtD
Propericiazine—Erectile dysfunction—Methotrexate—testicular cancer	0.00151	0.0026	CcSEcCtD
Propericiazine—Hyperhidrosis—Etoposide—testicular cancer	0.0015	0.00259	CcSEcCtD
Propericiazine—Photosensitivity reaction—Methotrexate—testicular cancer	0.0015	0.00257	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—testicular cancer	0.00149	0.00257	CcSEcCtD
Propericiazine—Diarrhoea—Dactinomycin—testicular cancer	0.00147	0.00253	CcSEcCtD
Propericiazine—Pneumonia—Methotrexate—testicular cancer	0.00147	0.00253	CcSEcCtD
Propericiazine—Vomiting—Bleomycin—testicular cancer	0.00146	0.00252	CcSEcCtD
Propericiazine—Drowsiness—Methotrexate—testicular cancer	0.00146	0.00252	CcSEcCtD
Propericiazine—Hypotension—Etoposide—testicular cancer	0.00145	0.0025	CcSEcCtD
Propericiazine—Rash—Bleomycin—testicular cancer	0.00145	0.0025	CcSEcCtD
Propericiazine—Dermatitis—Bleomycin—testicular cancer	0.00145	0.0025	CcSEcCtD
Propericiazine—Hypersensitivity—Ifosfamide—testicular cancer	0.00145	0.0025	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—testicular cancer	0.00142	0.00244	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—testicular cancer	0.0014	0.00242	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—testicular cancer	0.0014	0.00241	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—testicular cancer	0.00139	0.0024	CcSEcCtD
Propericiazine—Dyspnoea—Etoposide—testicular cancer	0.00139	0.00239	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—testicular cancer	0.00138	0.00238	CcSEcCtD
Propericiazine—Somnolence—Etoposide—testicular cancer	0.00138	0.00238	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—testicular cancer	0.00137	0.00237	CcSEcCtD
Propericiazine—Nausea—Bleomycin—testicular cancer	0.00137	0.00236	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—testicular cancer	0.00137	0.00235	CcSEcCtD
Propericiazine—Vomiting—Dactinomycin—testicular cancer	0.00137	0.00235	CcSEcCtD
Propericiazine—Agranulocytosis—Methotrexate—testicular cancer	0.00136	0.00235	CcSEcCtD
Propericiazine—Rash—Dactinomycin—testicular cancer	0.00135	0.00233	CcSEcCtD
Propericiazine—Diarrhoea—Ifosfamide—testicular cancer	0.00135	0.00232	CcSEcCtD
Propericiazine—Body temperature increased—Cisplatin—testicular cancer	0.00134	0.00231	CcSEcCtD
Propericiazine—Jaundice—Epirubicin—testicular cancer	0.00133	0.00229	CcSEcCtD
Propericiazine—Constipation—Etoposide—testicular cancer	0.00133	0.00229	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00129	0.00223	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—testicular cancer	0.00129	0.00222	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—testicular cancer	0.00128	0.0022	CcSEcCtD
Propericiazine—Nausea—Dactinomycin—testicular cancer	0.00128	0.0022	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—testicular cancer	0.00128	0.0022	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—testicular cancer	0.00127	0.00219	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—testicular cancer	0.00126	0.00218	CcSEcCtD
Propericiazine—Vomiting—Ifosfamide—testicular cancer	0.00125	0.00216	CcSEcCtD
Propericiazine—Hypersensitivity—Cisplatin—testicular cancer	0.00125	0.00215	CcSEcCtD
Propericiazine—Rash—Ifosfamide—testicular cancer	0.00124	0.00214	CcSEcCtD
Propericiazine—Dermatitis—Ifosfamide—testicular cancer	0.00124	0.00214	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—testicular cancer	0.00123	0.00212	CcSEcCtD
Propericiazine—Body temperature increased—Etoposide—testicular cancer	0.00123	0.00212	CcSEcCtD
Propericiazine—Cardiac disorder—Methotrexate—testicular cancer	0.00122	0.0021	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—testicular cancer	0.00118	0.00203	CcSEcCtD
Propericiazine—Nausea—Ifosfamide—testicular cancer	0.00117	0.00201	CcSEcCtD
Propericiazine—Diarrhoea—Cisplatin—testicular cancer	0.00116	0.002	CcSEcCtD
Propericiazine—Hypersensitivity—Etoposide—testicular cancer	0.00115	0.00197	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—testicular cancer	0.00114	0.00196	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—testicular cancer	0.0011	0.00189	CcSEcCtD
Propericiazine—Vomiting—Cisplatin—testicular cancer	0.00108	0.00186	CcSEcCtD
Propericiazine—Vision blurred—Methotrexate—testicular cancer	0.00108	0.00185	CcSEcCtD
Propericiazine—Rash—Cisplatin—testicular cancer	0.00107	0.00184	CcSEcCtD
Propericiazine—Dermatitis—Cisplatin—testicular cancer	0.00107	0.00184	CcSEcCtD
Propericiazine—Diarrhoea—Etoposide—testicular cancer	0.00106	0.00183	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—testicular cancer	0.00105	0.00181	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—testicular cancer	0.00101	0.00175	CcSEcCtD
Propericiazine—Nausea—Cisplatin—testicular cancer	0.00101	0.00174	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—testicular cancer	0.00101	0.00173	CcSEcCtD
Propericiazine—Vomiting—Etoposide—testicular cancer	0.000989	0.0017	CcSEcCtD
Propericiazine—Agitation—Epirubicin—testicular cancer	0.000981	0.00169	CcSEcCtD
Propericiazine—Rash—Etoposide—testicular cancer	0.00098	0.00169	CcSEcCtD
Propericiazine—Dermatitis—Etoposide—testicular cancer	0.00098	0.00169	CcSEcCtD
Propericiazine—Confusional state—Methotrexate—testicular cancer	0.000939	0.00162	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—testicular cancer	0.000931	0.0016	CcSEcCtD
Propericiazine—Infection—Methotrexate—testicular cancer	0.000925	0.00159	CcSEcCtD
Propericiazine—Nausea—Etoposide—testicular cancer	0.000924	0.00159	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—testicular cancer	0.000908	0.00156	CcSEcCtD
Propericiazine—Hyperhidrosis—Methotrexate—testicular cancer	0.0009	0.00155	CcSEcCtD
Propericiazine—Dry mouth—Epirubicin—testicular cancer	0.000889	0.00153	CcSEcCtD
Propericiazine—Confusional state—Epirubicin—testicular cancer	0.000879	0.00151	CcSEcCtD
Propericiazine—Oedema—Epirubicin—testicular cancer	0.000872	0.0015	CcSEcCtD
Propericiazine—Hypotension—Methotrexate—testicular cancer	0.00087	0.0015	CcSEcCtD
Propericiazine—Infection—Epirubicin—testicular cancer	0.000866	0.00149	CcSEcCtD
Propericiazine—Tachycardia—Epirubicin—testicular cancer	0.000851	0.00147	CcSEcCtD
Propericiazine—Hyperhidrosis—Epirubicin—testicular cancer	0.000843	0.00145	CcSEcCtD
Propericiazine—Insomnia—Methotrexate—testicular cancer	0.000842	0.00145	CcSEcCtD
Propericiazine—Dyspnoea—Methotrexate—testicular cancer	0.00083	0.00143	CcSEcCtD
Propericiazine—Somnolence—Methotrexate—testicular cancer	0.000828	0.00143	CcSEcCtD
Propericiazine—Dry mouth—Doxorubicin—testicular cancer	0.000823	0.00142	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—testicular cancer	0.000815	0.0014	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—testicular cancer	0.000813	0.0014	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—testicular cancer	0.000807	0.00139	CcSEcCtD
Propericiazine—Infection—Doxorubicin—testicular cancer	0.000801	0.00138	CcSEcCtD
Propericiazine—Insomnia—Epirubicin—testicular cancer	0.000788	0.00136	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—testicular cancer	0.000787	0.00136	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00078	0.00134	CcSEcCtD
Propericiazine—Dyspnoea—Epirubicin—testicular cancer	0.000777	0.00134	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—testicular cancer	0.000775	0.00133	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—testicular cancer	0.000754	0.0013	CcSEcCtD
Propericiazine—Constipation—Epirubicin—testicular cancer	0.000745	0.00128	CcSEcCtD
Propericiazine—Body temperature increased—Methotrexate—testicular cancer	0.000736	0.00127	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—testicular cancer	0.000729	0.00126	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—testicular cancer	0.000719	0.00124	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—testicular cancer	0.000717	0.00123	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—testicular cancer	0.00069	0.00119	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—testicular cancer	0.000689	0.00119	CcSEcCtD
Propericiazine—Hypersensitivity—Methotrexate—testicular cancer	0.000686	0.00118	CcSEcCtD
Propericiazine—Hypersensitivity—Epirubicin—testicular cancer	0.000642	0.00111	CcSEcCtD
Propericiazine—Body temperature increased—Doxorubicin—testicular cancer	0.000638	0.0011	CcSEcCtD
Propericiazine—Diarrhoea—Methotrexate—testicular cancer	0.000637	0.0011	CcSEcCtD
Propericiazine—Diarrhoea—Epirubicin—testicular cancer	0.000596	0.00103	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—testicular cancer	0.000594	0.00102	CcSEcCtD
Propericiazine—Vomiting—Methotrexate—testicular cancer	0.000592	0.00102	CcSEcCtD
Propericiazine—Rash—Methotrexate—testicular cancer	0.000587	0.00101	CcSEcCtD
Propericiazine—Dermatitis—Methotrexate—testicular cancer	0.000587	0.00101	CcSEcCtD
Propericiazine—Vomiting—Epirubicin—testicular cancer	0.000554	0.000954	CcSEcCtD
Propericiazine—Nausea—Methotrexate—testicular cancer	0.000553	0.000953	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—testicular cancer	0.000552	0.00095	CcSEcCtD
Propericiazine—Rash—Epirubicin—testicular cancer	0.00055	0.000946	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—testicular cancer	0.000549	0.000946	CcSEcCtD
Propericiazine—Nausea—Epirubicin—testicular cancer	0.000518	0.000892	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—testicular cancer	0.000513	0.000883	CcSEcCtD
Propericiazine—Rash—Doxorubicin—testicular cancer	0.000509	0.000876	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—testicular cancer	0.000508	0.000875	CcSEcCtD
Propericiazine—Nausea—Doxorubicin—testicular cancer	0.000479	0.000825	CcSEcCtD
